Patheon Unveils New Brand Image



    New Branding to be Launched at BIO2008 in San Diego This Week

    TORONTO, June 17 /CNW/ - Patheon (TSX:PTI), a global provider of drug
development and manufacturing services to the international pharmaceutical
industry, is pleased to unveil its new brand image. The new brand features a
new logo, new company colors and a new slogan that reflect Patheon's vision to
become the best provider of manufacturing and development services to the
pharmaceutical industry.
    "We wanted our new brand to carry the foundation of the past and the
promise for the future" said Terry Novak, President and Chief Marketing
Officer, "therefore our name remains the same but the corporate colors, logo
and slogan have been changed to reflect a new beginning and our commitment to
continuous improvement."
    Over the next few weeks Patheon will introduce the new brand in all of
its 11 facilities around the world, and will develop a series of external
promotions which more accurately reflect the company's broad range of services
and future direction.

    ABOUT PATHEON

    Patheon Inc. (TSX:PTI; www.patheon.com) is a leading global provider of
contract development and manufacturing services to the global pharmaceutical
industry. Patheon prides itself in providing the highest quality products and
services to more than 270 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical development
through commercial manufacturing of a full array of dosage forms including
parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative
technologies including single-use disposables, Liquid-Filled Hard Capsules and
a variety of modified release technologies.
    Patheon's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization. Patheon
can take customers direct to clinic with global clinical packaging and
distribution services and Patheon's Quick to Clinic(TM) programs can
accelerate early phase development project to clinical trials while minimizing
the consumption of valuable API.
    Patheon's integrated development and manufacturing network of 11
facilities, and 6 development centers across North America and Europe, strives
to ensure that customer products can be launched with confidence anywhere in
the world.

    Caution Concerning Forward-Looking Statements

    This news release may contain forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at www.patheon.com or on SEDAR at www.sedar.com.

    %SEDAR: 00001700E




For further information:

For further information: Mr. Wes Wheeler, President & Chief Executive
Officer, Tel: (905) 812-2112, Email: wes.wheeler@patheon.com; Mr. Terry Novak,
President of North America, Chief Marketing Officer, Tel: (862) 207-1262,
Email: terry.novak@patheon.com; Ms. Jean Treadwell, Investor Relations, Tel:
(905) 816-8344, Email: jean.treadwell@patheon.com

Organization Profile

Patheon Inc

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890